Cannabinoid-1 receptor antagonist rimonabant (SR141716) increases striatal dopamine D2 receptor availability

DSpace/Manakin Repository

Cannabinoid-1 receptor antagonist rimonabant (SR141716) increases striatal dopamine D2 receptor availability
 
Crunelle, C.L.; van der Giessen, E.; Schulz, S.; Vanderschuren, L.J.M.J.; de Bruin, K.; van den Brink, W.; Booij, J.
(2013) Addiction Biology, volume 18, issue 6, pp. 908 - 911
(Article)
Download/Full Text
Open Access version via Utrecht University Repository Publisher version
 
Keywords: Econometric and Statistical Methods: General, Geneeskunde (GENK), Geneeskunde(GENK), Medical sciences, Bescherming en bevordering van de menselijke gezondheid, Taverne
DOI: https://doi.org/10.1111/j.1369-1600.2011.00369.x
ISSN: 1355-6215
Publisher: Wiley-Blackwell
(Peer reviewed)
 
 
See more statistics about this item